I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Gross Profit
â‚Ş108.3m
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
32%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Gross Profit
$8.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
-3%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Gross Profit
$2.7m
CAGR 3-Years
-35%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
S
Seach Medical Group Ltd
TASE:SEMG
Gross Profit
â‚Ş42.5m
CAGR 3-Years
32%
CAGR 5-Years
44%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Gross Profit
â‚Ş75.4m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
-2%
No Stocks Found

InterCure Ltd
Glance View

Market Cap
239.6m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 796.79 ILS
Undervaluation 72%
Intrinsic Value
Price
I

See Also

What is InterCure Ltd's Gross Profit?
Gross Profit
108.3m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Gross Profit amounts to 108.3m ILS.

What is InterCure Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
32%

Over the last year, the Gross Profit growth was -32%. The average annual Gross Profit growth rates for InterCure Ltd have been 53% over the past three years , and 32% over the past ten years .

Back to Top